Citigroup’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Other funds holding RCKT
NM
Citigroup's RCKT Position: Q3 2026 in Review
Citigroup reduced its Rocket Pharmaceuticals (RCKT) stake by 5.3% in Q3 2026, selling an estimated $888K and leaving 4,609,231 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1490.
Citigroup first reported a position in RCKT in Q1 2015 and has held it in 41 quarters since. The position peaked at $18.4M in Q4 2025. 174 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.
- Citigroup held 4,609,231 shares of Rocket Pharmaceuticals worth $12.1M as of Q3 2026.
- Citigroup sold 256,320 Rocket Pharmaceuticals shares in Q3 2026, an estimated $888K.
- Rocket Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #1490 holding.
- Citigroup first reported a position in Rocket Pharmaceuticals in Q1 2015 and has held it in 41 quarters since.
- Citigroup's Rocket Pharmaceuticals position peaked at $18.4M in Q4 2025.
- 174 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.